SCHEMBL13701575

SCHEMBL13701575

CCOc1cc(-c2nc(CCC(=O)c3ncccc3C)co2)ccc1O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.37
KDM4E B2RXH2 3/20 0.37
KMT2A Q03164 2/20 0.37
NPC1 O15118 1/20 0.37
GLA P06280 1/20 0.37
GUSB P08236 1/20 0.37
GAA P10253 1/20 0.36
TP53 P04637 2/20 0.36
CSNK2A2 P19784 2/20 0.36
CSNK2B P67870 2/20 0.36
CSNK2A1 P68400 2/20 0.36
S1PR1 P21453 4/20 0.35
POLB P06746 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PPARG P37231 1/20 0.35
PPARA Q07869 1/20 0.35
MAPK1 P28482 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4273608 0.93 S1PR1 (0.42) MAPTKDM4EKMT2ANPC1S1PR1
SCHEMBL4269872 0.90 SMN1; SMN2 (0.42) MAPTKDM4EKMT2ANPC1S1PR1
SCHEMBL4277067 0.89 FFAR1 (0.34) MAPTTP53S1PR1PPARGPPARA
SCHEMBL13701625 0.89 PPARG (0.38) MAPTTP53S1PR1PPARGPPARA
SCHEMBL8231482 0.88 PLAA (0.38) MAPTKDM4EKMT2AGAAPOLB
SCHEMBL4282871 0.88 FFAR1 (0.34) MAPTTP53PPARGPPARA
SCHEMBL4281548 0.87 PDE4A (0.37) MAPTKDM4ENPC1TP53S1PR1
SCHEMBL4278848 0.87 S1PR1 (0.36) MAPTKDM4ENPC1TP53S1PR1
SCHEMBL4275333 0.86 S1PR1 (0.38) MAPTKDM4EKMT2ANPC1S1PR1
SCHEMBL4276071 0.86 MGAM (0.37) MAPTGAAPOLBSMN1; SMN2PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090221586-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221586-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A MAPT 4667/4885KDM4E 1260/4885KMT2A 2947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.